News
"The favorable tolerability and pharmacokinetic profile observed with CVN293 in this first-in-human study are promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback